ABOS · Acumen Pharmaceuticals, Inc. · Fails to Deliver
$0.19
-0.01 (-3.52%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Oct 26, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current operating plan, we believe there is substantial doubt about our ability to continue as a going concern for at least 12 months following the date of issuance of our unaudited condensed financial statements included in this Quarterly Report on Form 10-Q.”View the 10-Q filed Oct 26, 2026
Market Cap
$13.49M
Shares
72.33M
Volume · Nov 20
2.71M
Avg daily vol (3M)
2.7M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-30 | 23,144 | $2.29 | $53,000 |
| 2026-10-26 | 869 | $1.98 | $1,721 |
| 2026-10-19 | 7,040 | $1.69 | $11,898 |
| 2026-10-13 | 5,695 | $2.02 | $11,504 |
| 2026-10-08 | 920 | $2.10 | $1,932 |
| 2026-10-07 | 2 | $2.03 | $4 |
| 2026-10-01 | 1,831 | $2.22 | $4,065 |
| 2026-09-30 | 13,347 | $2.25 | $30,031 |
| 2026-09-28 | 6,016 | $2.24 | $13,476 |
| 2026-09-22 | 3,538 | $2.59 | $9,163 |
| 2026-09-08 | 52 | $3.18 | $165 |
| 2026-08-31 | 150 | $2.92 | $438 |
Showing 1–12 of 12 settlements
Key facts
CIK
1576885
CUSIP
00509G209
13F (30d)
103 filings
89 filers
Visit website
Investor relations